medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2019-13-70-72medsovet-3922Research ArticleБеременность и родыPregnancy and childbirthLactobacillus fermentum CECT5716 – профилактика и лечение лактационного маститаLactobacillus fermentum CECT5716 – prevention and treatment of lactational mastitishttps://orcid.org/0000-0001-8555-144XКарапетянА. О.KarapetyanA. О.

Карапетян Анна Овиковна, врач 1-го родильного отделения, ассистент кафедры акушерства и гинекологии департамента профессионального образования

117997, Москва, ул. Академика Опарина, д. 4 

Anna O. Karapetyan, Doctor of the 1st Maternity Department, Assistant of the Department of Obstetrics and Gynecology of the Department of Professional Education

4, Oparina str., Moscow, 117997

anne-89@mail.ruНациональный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. КулаковаРоссияFederal State Budgetary Institution «National Medical Research Center of Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov» of the Ministry of Health of the Russian FederationRussian Federation2019101020190137072Copyright © Карапетян А.О., 20192019Карапетян А.О.Karapetyan A.О.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/3922Цель исследования

Цель исследования: представить анализ данных литературы о роли применения Lactobacillus fermentum CECT5716 в профилактике и лечении послеродовых лактационных осложнений.

Материалы и методы

Материалы и методы: проведен поиск литературных источников, опубликованных в базе данных Pubmed, Scopus.

Результаты

Результаты: по данным рандомизированных клинических исследований применение Lactobacillus fermentum CECT5716 в послеродовом периоде родильницей приводит к коррекции микробиоты молочной железы путем снижения количества патогенных и увеличения молочнокислых бактерий, уменьшения содержания воспалительных факторов в грудном молоке.

Заключение

Заключение: Lactobacillus fermentum CECT5716 является эффективным и безопасным средством для профилактики и лечения послеродовых лактационных осложнений.

Aim of the study: To present an analysis of the literature data on the role of Lactobacillus fermentum CECT5716 in the prevention and treatment of postpartum lactation complications. Materials and methods: literature sources published in the Pubmed, Scopus database were searched. Results: according to randomized clinical studies, the use of Lactobacillus fermentum CECT5716 in the postnatal period by mothers leads to the correction of breast microbiota by reducing the number of pathogenic bacteria and increasing lactic-acid bacteria, reducing the content of inflammatory factors in breast milk. Conclusion: Lactobacillus fermentum CECT5716 is an effective and safe way to prevent and treat postpartum lactation complications.

Lactobacillus fermentum CECT5716лактостазмаститгрудное вскармливаниеLactobacillus fermentum CECT5716lactostasismastitisbreastfeedingReferencesLucas A. long-term programming effects of early nutrition – implications for the preterm infant. J Perinatol. 2005;25(Suppl. 2):2–6. doi: 10.1038/sj.jp.7211308.Lucas A. long-term programming effects of early nutrition – implications for the preterm infant. J Perinatol. 2005;25(Suppl. 2):2–6. doi: 10.1038/sj.jp.7211308.Horta B.L., Bahl R., Martines J.C., Victora C.G. Evidence on the long-term effects of breastfeeding. Geneva: World Health Organization. 2007. Available at: https://apps.who.int/iris/bitstream/handle/10665/43623/9789241595230_eng.pdf;jsessionid=F2A7AC116D622445CC092E46A812A9E6?sequence=1.Horta B.L., Bahl R., Martines J.C., Victora C.G. Evidence on the long-term effects of breastfeeding. Geneva: World Health Organization. 2007. Available at: https://apps.who.int/iris/bitstream/handle/10665/43623/9789241595230_eng.pdf;jsessionid=F2A7AC116D622445CC092E46A812A9E6?sequence=1.Victora C.G., Bahl R., Barros A.J.D., Franca G.V.A., Horton S., Krasevec J., Murch S., Sankar M.J., Walker N., Rollins N.C. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475490. doi: 10.1016/S0140-6736(15)01024-7.Victora C.G., Bahl R., Barros A.J.D., Franca G.V.A., Horton S., Krasevec J., Murch S., Sankar M.J., Walker N., Rollins N.C. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect. Lancet. 2016;387(10017):475490. doi: 10.1016/S0140-6736(15)01024-7.Global strategy for infant and young child feeding. Geneva: World Health Organization. 2003. Available at: https://apps.who.int/iris/bitstream/handle/10665/42590/9241562218.pdf?sequence=1.Global strategy for infant and young child feeding. Geneva: World Health Organization. 2003. Available at: https://apps.who.int/iris/bitstream/handle/10665/42590/9241562218.pdf?sequence=1.Kramer M.S., Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2012;(8):CD003517. doi: 10.1002/14651858.CD003517.pub2.Kramer M.S., Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2012;(8):CD003517. doi: 10.1002/14651858.CD003517.pub2.Ziegler E.E. Human milk-A valuable tool in the early days of life of premature infants. Front Pediatr. 2019;7:266. doi: 10.3389/fped.2019.00266.Ziegler E.E. Human milk-A valuable tool in the early days of life of premature infants. Front Pediatr. 2019;7:266. doi: 10.3389/fped.2019.00266.Zachou G., Armeni E., Lambrinoudaki I. Lactation and maternal cardiovascular disease risk in later life. Maturitas. 2019;122:73-79. doi: 10.1016/j.maturitas.2019.01.007.Zachou G., Armeni E., Lambrinoudaki I. Lactation and maternal cardiovascular disease risk in later life. Maturitas. 2019;122:73-79. doi: 10.1016/j.maturitas.2019.01.007.Borra C., Iacovou M., Sevilla A. New evidence on breastfeeding and postpartum depression: the importance of understanding women’s intentions. Matern Child Health J. 2015;19(4):897-907. doi: 10.1007/s10995-014-1591-z.Borra C., Iacovou M., Sevilla A. New evidence on breastfeeding and postpartum depression: the importance of understanding women’s intentions. Matern Child Health J. 2015;19(4):897-907. doi: 10.1007/s10995-014-1591-z.Islami F., Liu Y., Jemal A., Zhou J., Weiderpass E., Colditz G., Boffetta P., Weiss M. Breastfeeding and breast cancer risk by receptor status – a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398-2407. doi: 10.1093/annonc/mdv379.Islami F., Liu Y., Jemal A., Zhou J., Weiderpass E., Colditz G., Boffetta P., Weiss M. Breastfeeding and breast cancer risk by receptor status – a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398-2407. doi: 10.1093/annonc/mdv379.Jordan S.J., Na R., Johnatty S.E., Wise L.A., Adami H.O., Brinton L.A., Chen C., Cook L.S., Maso L.D., Vivo I.D., Freudenheim J.L., Friedenreich C.M., La Vecchia C., McCann S.E., Moysich K.B., Lu L., Olson S.H., Palmer J.R., Retruzella S., Pike M.C., Rebbeck T.R., Ricceri F., Risch H.A., Sacerdote C., Setiawan V.W., Sponholtz T.R., Shu X.O., Spurdle A.B., Weiderpass E., Wentzensen N., Yang H.P., Yu H., Webb P.M. Breastfeeding and endometrial cancer risk: an analysis from the epidemiology of endometrial cancer consortium. Obstet Gynecol. 2017;129(6):1059-1067. doi: 10.1097/AOG.0000000000002057.Jordan S.J., Na R., Johnatty S.E., Wise L.A., Adami H.O., Brinton L.A., Chen C., Cook L.S., Maso L.D., Vivo I.D., Freudenheim J.L., Friedenreich C.M., La Vecchia C., McCann S.E., Moysich K.B., Lu L., Olson S.H., Palmer J.R., Retruzella S., Pike M.C., Rebbeck T.R., Ricceri F., Risch H.A., Sacerdote C., Setiawan V.W., Sponholtz T.R., Shu X.O., Spurdle A.B., Weiderpass E., Wentzensen N., Yang H.P., Yu H., Webb P.M. Breastfeeding and endometrial cancer risk: an analysis from the epidemiology of endometrial cancer consortium. Obstet Gynecol. 2017;129(6):1059-1067. doi: 10.1097/AOG.0000000000002057.Ballard O., Morrow A.L. Human milk composition. Pediatr Clin North Am. 2013;60(1):49-74. doi: 10.1016/j.pcl.2012.10.002.Ballard O., Morrow A.L. Human milk composition. Pediatr Clin North Am. 2013;60(1):49-74. doi: 10.1016/j.pcl.2012.10.002.Urbaniak C., Cummins J., Brackstone M., Macklaim J.M., Gloor G.B., Baban C.K., Scott L., O’Hanlon D.M., Burton J.P., Francis K.P., Tangney M., Reid G. Microbiota of human breast tissue. Applied and Enviromental Microbiology. 2014;80(10):3007-3014. doi: 10.1128/AEM.00242-14.Urbaniak C., Cummins J., Brackstone M., Macklaim J.M., Gloor G.B., Baban C.K., Scott L., O’Hanlon D.M., Burton J.P., Francis K.P., Tangney M., Reid G. Microbiota of human breast tissue. Applied and Enviromental Microbiology. 2014;80(10):3007-3014. doi: 10.1128/AEM.00242-14.Martin R., Langa S., Reviriego C., Jimenez E., Marin M.L., Xaus J., Fernandez L., Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754758. doi: 10.1016/j.jpeds.2003.09.028.Martin R., Langa S., Reviriego C., Jimenez E., Marin M.L., Xaus J., Fernandez L., Rodriguez J.M. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143(6):754758. doi: 10.1016/j.jpeds.2003.09.028.Togo A., Dufour J.C., Lagier J.C., Dubourg G., Raoult D., Million M. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol. 2019;14:623-641. doi: 10.2217/fmb-2018-0317.Togo A., Dufour J.C., Lagier J.C., Dubourg G., Raoult D., Million M. Repertoire of human breast and milk microbiota: a systematic review. Future Microbiol. 2019;14:623-641. doi: 10.2217/fmb-2018-0317.Yu Z., Sun S., Zhang Y. High-risk factors for suppurative mastitis in lactating women. Med Sci Monit. 2018;24:4192-4197. doi: 10.12659/MSM.909394.Yu Z., Sun S., Zhang Y. High-risk factors for suppurative mastitis in lactating women. Med Sci Monit. 2018;24:4192-4197. doi: 10.12659/MSM.909394.Contreras G.A., Rodriguez J.M. Mastitis: comparative etiology and epidemiology. J Mammary Gland Biol Neoplasia. 2011;16(4):339-356. doi: 10.1007/s10911-011-9234-0.Contreras G.A., Rodriguez J.M. Mastitis: comparative etiology and epidemiology. J Mammary Gland Biol Neoplasia. 2011;16(4):339-356. doi: 10.1007/s10911-011-9234-0.Maldonado-Lobon J.A., Diaz-Lopez M.A., Carputo R., Duarte P., Diaz-Ropero M.P., Valero A.D., Sanudo A., Sempere L., Ruiz-Lopez M.D., Banuelos O., Fonolla J., Martin M.O. Lactobacillus fermentum CECT 5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeed Med. 2015;10(9):425-432. doi: 10.1089/bfm.2015.0070.Maldonado-Lobon J.A., Diaz-Lopez M.A., Carputo R., Duarte P., Diaz-Ropero M.P., Valero A.D., Sanudo A., Sempere L., Ruiz-Lopez M.D., Banuelos O., Fonolla J., Martin M.O. Lactobacillus fermentum CECT 5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeed Med. 2015;10(9):425-432. doi: 10.1089/bfm.2015.0070.Olivares M., Diaz-Ropero M.P., Martin R., Rodriguez J.M., Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbol. 2006;101(1): 72-79. doi: 10.1111/j.1365-2672.2006.02981.x.Olivares M., Diaz-Ropero M.P., Martin R., Rodriguez J.M., Xaus J. Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbol. 2006;101(1): 72-79. doi: 10.1111/j.1365-2672.2006.02981.x.Diaz-Ropero M.P., Martin R., Sierra S., LaraVilloslada F., Rodriguez J.M., Xaus J., Olivares M. Two Lactobacillus strains isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337-343. doi: 10.1111/j.1365-2672.2006.03102.xDiaz-Ropero M.P., Martin R., Sierra S., LaraVilloslada F., Rodriguez J.M., Xaus J., Olivares M. Two Lactobacillus strains isolated from breast milk, differently modulate the immune response. J Appl Microbiol. 2007;102(2):337-343. doi: 10.1111/j.1365-2672.2006.03102.xHunt K.M., Williams J.E., Shafii B., Hunt M.K., Behre R., Ting R., McGuire M.K., McGuire M.A. Mastitis is associates with increased free fatty acids, somatic cell count, and interleukin-8 concentrations in human milk. Breastfeed Med. 2013;8(1):105-110. doi: 10.1089/bfm.2011.0141.Hunt K.M., Williams J.E., Shafii B., Hunt M.K., Behre R., Ting R., McGuire M.K., McGuire M.A. Mastitis is associates with increased free fatty acids, somatic cell count, and interleukin-8 concentrations in human milk. Breastfeed Med. 2013;8(1):105-110. doi: 10.1089/bfm.2011.0141.Bond D.M., Morris J.M., Nassar N. Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT 5716 for the prevention of mastitis in breastfeeding women: a randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):148. doi: 10.1186/s12884-017-1330-8.Bond D.M., Morris J.M., Nassar N. Study protocol: evaluation of the probiotic Lactobacillus Fermentum CECT 5716 for the prevention of mastitis in breastfeeding women: a randomized controlled trial. BMC Pregnancy Childbirth. 2017;17(1):148. doi: 10.1186/s12884-017-1330-8.Gil-Campos M., Lopez M.A., Rodriquez-Benitez M.V., Romero J., Roncero I., Linares M.D., Maldonado J., Lopez-Huertas E., Berwind R., Ritzenthaler K.L., Navas V., Sierra C., Sempere L., Geelings A., Maldonado-Lobon J.A., Valero A.D., Lara-Villoslada F., Olivares M. Lactobacillus Fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacol Res. 2012;65(2):231-238. doi: 10.1016/j.phrs.2011.11.016.Gil-Campos M., Lopez M.A., Rodriquez-Benitez M.V., Romero J., Roncero I., Linares M.D., Maldonado J., Lopez-Huertas E., Berwind R., Ritzenthaler K.L., Navas V., Sierra C., Sempere L., Geelings A., Maldonado-Lobon J.A., Valero A.D., Lara-Villoslada F., Olivares M. Lactobacillus Fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacol Res. 2012;65(2):231-238. doi: 10.1016/j.phrs.2011.11.016.Maldonado J., Canabate F., Sempere L., Vela F., Sanchez A.R., Narbona E., Lopez-Huertas E., Geeling A., Valero A.D., Olivares M., LaraVilloslada F. Human milk probiotic Lactobacillus Fermentum CECT 5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr. 2012;54(1):55-61. doi: 10.1097/MPG.0b013e3182333f18.Maldonado J., Canabate F., Sempere L., Vela F., Sanchez A.R., Narbona E., Lopez-Huertas E., Geeling A., Valero A.D., Olivares M., LaraVilloslada F. Human milk probiotic Lactobacillus Fermentum CECT 5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. J Pediatr Gastroenterol Nutr. 2012;54(1):55-61. doi: 10.1097/MPG.0b013e3182333f18.

The authors declare that there are no conflicts of interest present.